Announcement on Voluntary Disclosure of Ethical Review Approval for Phase II Clinical Trial of Antivenom Serum against Viper Venom

About this update from Shanghai Serum Bio-technology Co., Ltd. Class A

Announcement on Voluntary Disclosure of Ethical Review Approval for Phase II Clinical Trial of Antivenom Serum against Viper VenomThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:" target="_blank">View Attachment

View stock analysis, news, and events for Shanghai Serum Bio-technology Co., Ltd. Class A